M2I Life Sciences was founded in 2013 and has positioned itself as a premier industrial partner in France for specialized product synthesis and formulation across various industries including Healthcare, veterinary medicine, biological crop protection, and organic electronics. The company's core focus lies in developing synthetic routes and industrial processes for complex molecules, offering a comprehensive service from specification to regulatory approval. With both an R&D center and a cGMP manufacturing facility in France, the company has recently secured a Debt Financing investment from Bootstrap Europe on 14 November 2020.
General Information
BounceWatch is an independent company data service, not affiliated with M2I Life Sciences. To contact M2I Life Sciences, visit m2i-lifesciences.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Biotechnology
About M2I Life Sciences
Funding Rounds & Investors (3)
View AllFAQ About M2I Life Sciences
We're actively collecting intelligence on M2I Life Sciences.
Source: BounceWatch company record for M2I Life Sciences, https://bouncewatch.com/company/m2i-life-sciences, updated 27 December 2024. When citing, please name BounceWatch and link this page.